Triple-negative breast cancer (TNBC) and HER2+ breast cancer are characterized by higher levels of TILs, including T, B, and natural killer (NK) cells [42,43,44], than hormone receptor-positive cancers [45,46,47,48]. This evidence concerns the gene ERBB2 and breast carcinoma.